NASDAQ · LFWDHealthcareOrthopedic & Surgical Supplies

Lifeward financials

$6.91−0.14%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$22.0M$25.7M
Gross profit$8.4M$8.2M
Gross margin38.3%32.0%
Operating income-$19.7M-$29.3M
Net income-$19.9M-$28.9M
Net margin−90.4%−112.8%
Diluted EPS$-17.16$-39.96
EBITDA-$16.6M-$15.7M
Operating cash flow-$16.8M-$21.7M
Free cash flow-$16.8M-$21.7M
Diluted shares1.2M0.7M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$2.2M$6.7M
Short-term investments$0.00$0.00
Total debt$2.8M$0.00
Total assets$22.9M$30.5M
Total liabilities$14.5M$11.6M
Shareholders' equity$8.4M$18.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology